Medication info
Fritozeng 40 mg (Telmisartan)

Fritozeng 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Kwangdong Pharm Co., Ltd.
Appearance
White or whitish, biconvex oval tablet
Packaging
30 tablets/box [(10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 200108691 · Approved 2001.04.20 · Insurance code 641806570

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Importer
Kwangdong Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • clinical evidence of end-organ damage in high-risk diabetes
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension. Additionally, it is used in patients aged 55 and older who are at high risk of cardiovascular diseases such as coronary artery disease or stroke, to reduce the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. This drug serves as a good alternative for patients intolerant to ACE inhibitors and protects cardiovascular health. Therefore, it is used effectively for essential hypertension and reducing the risk of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients who are allergic to this medication, pregnant or breastfeeding women, patients with severe liver disease or cholestasis, patients with hereditary angioedema, and patients with diabetes or severe renal impairment should not take it. Elderly patients, those with hyperkalemia, patients with mild to moderate liver impairment, heart valve disease, cardiovascular disease, gastrointestinal disease, renal artery hypertension, and severe renal impairment should use this medication with caution. While taking this medication, various adverse reactions such as blood pressure drop, hyperkalemia, renal function impairment, angioedema, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, so patients should consult healthcare professionals immediately if symptoms appear. Particular caution is needed if blood pressure drops too low or if dizziness or fainting occurs, and regular monitoring of renal function and electrolyte levels is required. This medication can increase the blood pressure-lowering effect when used with other antihypertensive agents, so patients should inform their healthcare provider about any concomitant medications. Caution is needed when used with lithium, certain diuretics, potassium supplements, NSAIDs, etc., as the risk of side effects may increase. It is advisable not to take this medication within 24 hours before surgery, and caution should be exercised while driving or operating machinery due to risks of dizziness or fainting. This medication contains sorbitol, so it is advisable not to take it if you have fructose intolerance. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should also avoid using it or discontinue breastfeeding. Safety and efficacy in patients under 18 years of age have not been established, so it is not recommended. In case of overdose, symptoms like hypotension, dizziness, acute renal failure may occur, so appropriate medical treatment should be sought immediately.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 124 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • abnormal liver function
  • liver disorders
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • hand tremors
  • reduced concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal-laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • blood pressure drop
  • interstitial pneumonia
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • elevated urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • cough
  • dyspepsia
  • palpitations
  • facial spasms
  • sensory disturbance
  • paralysis
  • hyperventilation
  • pneumonia
  • flush
  • erectile dysfunction
  • anorexia
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • anorexia
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees. This ensures that the medication's effectiveness is maintained for a longer time.

Appearance and packaging

Appearance

White or whitish, biconvex oval tablet

Package unit

30 tablets/box [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.